ANSWERS SOLUTION
molecular pharmacology - ANS IS the study of the chemical structures of drugs and
their actions at the molecular level within a cell is called
Pharmacogenomics - ANS IS use of information about a person's genetic makeup, or
genome, to choose the drugs and drug doses that are likely to work best for that person
generic name - ANS IS The United Stated Adopted name is considered to be the drugs
____________
Trade Name - ANS IS The brand name that a manufacturer gives a medication;
the name is capitalized.
In Vivo - ANS IS This term means testing on animals or humans
In Vitro - ANS IS This term means testing in glass
Pharmacodynamics - ANS IS drug effects based on time and dose
half-life - ANS IS The time required for the drug level in the blood to decrease form
100% to 50%
Pharmacokinetics - ANS IS the study of drug movement throughout the body
Inert ingredients - ANS IS Filler / non-drug ingredients in medication which are inactive.
Desiccant - ANS IS a substance used to absorb moisture from the air and create a dry
atmosphere
National Drug Code (NDC) - ANS IS Unique 10 or 11 identification number given to
drugs that contains 3 sections Manufacturer, drug strength/dose and drug size/type
Federal Trade Commission (FTC) - ANS IS The agency that regulates the marketing
and advertising of over the counter drugs
Post-marketing surveillance - ANS IS Monitoring safety of medications/devices
AFTER they have been released on the market
drug recall - ANS IS Medications are taken off the market if there is a reasonable
probability that use will result in serious adverse health consequences or death
Bioavailability - ANS IS the rate at and the extent to which a nutrient is absorbed and
used
, Control Group - ANS IS the group that does not receive the experimental treatment.
Placebo - ANS IS A harmless pill, that is usually received by the control group is called
Pharmacogenetics - ANS IS the study of how genetic variation affects an individual's
response to drugs
Isomers - ANS IS Compounds with the same formula but different structures.
Recombinant DNA technology - ANS IS technology that combines genes from
different sources into a single DNA molecule
Recombinant DNA Advisory Committee - ANS IS group of physicians and
pharmacists that review clinical trials of genetically engineered drugs and then makes
recommendations to the FDA
therapeutic index - ANS IS the ratio between the toxic and therapeutic concentrations
of a drug
median effective dose - ANS IS Dose required to produce a specified intensity of
effect in 50% of the animals
active ingredient - ANS IS Generic drugs and trade name drugs that are in the
same drug form and drug strength--even if they are from different drug companies-
must contain exactly the same amount of
It can be marketed - ANS IS No matter how a drug was originally discovered or
designed, it must be thoroughly tested by the drug company
before_____________________.
FTC (Federal Trade Commission) - ANS IS ___________is over advertising of over the
counter drugs
MedWatch - ANS IS ________________________ is the FDA safety information and
adverse event reporting system on the Internet.
MEDMARX - ANS IS A national Internet-accessible database that hospitals and
health care systems use to track adverse drug reactions and medication errors.
Investigational new drug application - ANS IS When animal studies are completed, the
drug company submits a(n) ____________ application to the FDA.
Median effective dose (ED50) - ANS IS the dose of a drug that produces a therapeutic
response in 50% of the animals tested